Detalles de la búsqueda
1.
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
Eur J Immunol
; 50(1): 119-129, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31424086
2.
Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sjögren's syndrome.
Rheumatology (Oxford)
; 60(7): 3072-3087, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838419
3.
Epigenetically quantified immune cells in salivary glands of Sjögren's syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopathology.
Rheumatology (Oxford)
; 59(2): 335-343, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325310
4.
Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Scand J Immunol
; 91(3): e12852, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733111
5.
Dysregulated miRNome of plasmacytoid dendritic cells from patients with Sjögren's syndrome is associated with processes at the centre of their function.
Rheumatology (Oxford)
; 58(12): 2305-2314, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31131409
6.
Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Rheumatology (Oxford)
; 58(10): 1740-1745, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31220315
7.
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
J Autoimmun
; 89: 162-170, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29371048
8.
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.
RMD Open
; 9(3)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532471
9.
CCL5 Release by CCR9+ CD8 T Cells: A Potential Contributor to Immunopathology of Primary Sjögren's Syndrome.
Front Immunol
; 13: 887972, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35720379
10.
The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
Front Immunol
; 12: 701656, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413853
11.
Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren's Syndrome Patients Identifies CCL5 as a Novel Effector Molecule.
Front Immunol
; 12: 702733, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34386009
12.
Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
Front Immunol
; 10: 2096, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31552042
13.
Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
RMD Open
; 5(1): e000772, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30713719
14.
MicroRNA-130a Contributes to Type-2 Classical DC-activation in Sjögren's Syndrome by Targeting Mitogen- and Stress-Activated Protein Kinase-1.
Front Immunol
; 10: 1335, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31281310
15.
Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.
PLoS One
; 13(2): e0193157, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447268
16.
Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Front Immunol
; 9: 1200, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29922285
17.
Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
Arthritis Rheumatol
; 69(10): 2038-2051, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28622456
18.
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren's syndrome is associated with B cell hyperactivity and type I interferon activity.
RMD Open
; 6(2)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32540951
19.
Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
RMD Open
; 5(1): e000701, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30713717
Resultados
1 -
19
de 19
1
Próxima >
>>